🔗 Permalink

Inventor profile of:

Anthony Coyle

City:

Boston, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2025-08-14

Top Assignees for applications by Anthony Coyle

The entities that hold a legal rights for patent applications filed by inventor Coyle Anthony:

MEDIMMUNE, LLC 6 Gaithersburg, MD United States
Viela Bio, Inc. 3 GAITHERSBURG, MD United States
Medlmmune, LLC 2 Gaithersburg, MD United States
AstraZeneca AB 2 Sodertalje, Sweden
Abbott Laboratories 1 Abbott Park, IL United States
Viela Bio, Inc. 1 Deerfield, IL United States
MedImmune Limited 1 Cambridge, United Kingdom
MCMASTER UNIVERSITY 1 Hamilton, ON Canada

Recent patent applications by Coyle Anthony

Anthony Coyle from Boston, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-08-14

US20250257120A1

Chemistry; metallurgy

COMPOSITIONS COMPRISING A TN3 SCAFFOLD AND METHODS OF USING THE SAME

#2 | 2025-03-27

US20250101116A1

Chemistry; metallurgy

ANTI-IFNAR1 ANTIBODIES WITH REDUCED FC LIGAND AFFINITY

#3 | 2024-12-19

US20240417460A1

Chemistry; metallurgy

HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE

#4 | 2023-08-03

US20230242619A1

Chemistry; metallurgy

COMPOSITIONS COMPRISING A TN3 SCAFFOLD AND METHODS OF USING THE SAME

#5 | 2022-03-24

US20220089688A1

Chemistry; metallurgy

Methods of administering a composition comprising a Tn3 scaffold and a CD40L-specific monomer

#6 | 2021-03-04

US20210061906A1

Chemistry; metallurgy

HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE

#7 | 2020-06-04

US20200172625A1

Chemistry; metallurgy

ANTI-IFNAR1 ANTIBODIES WITH REDUCED FC LIGAND AFFINITY

#8 | 2020-02-20

US20200055944A1

Chemistry; metallurgy

ANTI-IFNAR1 ANTIBODIES WITH REDUCED FC LIGAND AFFINITY

#9 | 2018-11-01

US20180312572A1

Chemistry; metallurgy

Nucleic acids encoding a Tn3 scaffold comprising a CD40L-specific monomer subunit

#10 | 2018-09-27

US20180273621A1

Chemistry; metallurgy

HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE

#11 | 2018-08-30

US20180244791A1

Chemistry; metallurgy

Anti-IFNAR1 antibodies with reduced Fc ligand affinity

#12 | 2018-05-03

US20180118839A1

Chemistry; metallurgy

Anti-IFNAR1 antibodies with reduced Fc ligand affinity

#13 | 2017-04-13

US20170101468A1

Chemistry; metallurgy

HUMAN ANTI IL-6 ANTIBODIES WITH EXTENDED IN VIVO HALF-LIFE AND THEIR USE IN TREATMENT OF ONCOLOGY, AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES

#14 | 2016-05-26

US20160145335A1

Chemistry; metallurgy

Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

#15 | 2015-05-28

US20150147336A1

Chemistry; metallurgy

INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS AND USES THEREOF

#16 | 2015-04-09

US20150098955A1

Chemistry; metallurgy

CD40L-specific TN3-derived scaffolds and methods of use thereof

#17 | 2015-02-12

US20150044222A1

Chemistry; metallurgy

INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS AND USES THEREOF

#18 | 2014-10-09

US20140302058A1

Chemistry; metallurgy

HUMAN ANTI IL-6 ANTIBODIES WITH EXTENDED IN VIVO HALF-LIFE AND THEIR USE IN TREATMENT OF ONCOLOGY, AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES

#19 | 2013-10-10

US20130266566A1

Chemistry; metallurgy

METHODS OF INHIBITING FIBROSIS USING ANTI-PAI-1 ANTIBODIES

#20 | 2013-06-13

US20130149312A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING COPD EXACERBATION

#21 | 2013-06-06

US20130142783A1

Chemistry; metallurgy

Anti-ICOS antibodies and their use in treatment of oncology, transplantation and autoimmune disease

#22 | 2013-05-09

US20130115657A1

Chemistry; metallurgy

Humanized anti-CD19 antibodies

#23 | 2012-02-09

US20120034212A1

Chemistry; metallurgy

Human Anti-IL-6 Antibodies With Extended In Vivo Half-Life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases

#24 | 2011-11-24

US20110287022A1

Chemistry; metallurgy

INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS

#25 | 2011-10-06

US20110243929A1

Chemistry; metallurgy

ANTI-ICOS ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE

#26 | 2011-03-10

US20110059078A1

Chemistry; metallurgy

ANTI-IFNAR1 ANTIBODIES WITH REDUCED FC LIGAND AFFINITY

InventorID:

235109 ⎘